TYPE 2 DIABETES MELLITUS (T2DM)
Clinical trials for TYPE 2 DIABETES MELLITUS (T2DM) explained in plain language.
Never miss a new study
Get alerted when new TYPE 2 DIABETES MELLITUS (T2DM) trials appear
Sign up with your email to follow new studies for TYPE 2 DIABETES MELLITUS (T2DM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New kidney pill aims to cut protein leak in diabetics
Disease control Not yet recruitingThis study tests whether the drug finerenone can reduce protein in the urine (a sign of kidney damage) in adults with type 2 diabetes and chronic kidney disease. About 148 participants will receive either finerenone or a placebo pill daily for 6 months, on top of their usual medi…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Phase: PHASE4 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated Jun 27, 2026 14:03 UTC
-
New simple workout could help control diabetes
Disease control Not yet recruitingThis study tests a new, simpler weight training program called D-STORM for adults with type 2 diabetes. The program uses easier exercises to build muscle and improve blood sugar control. Over 12 weeks, 56 participants will either do the training plus usual care or just usual care…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Phase: NA • Sponsor: Universiti Teknologi Mara • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Could a shot every two weeks beat weekly diabetes drugs?
Disease control Not yet recruitingThis study tests a new medicine called bofanglutide (GZR18) for adults with type 2 diabetes whose blood sugar is not well controlled with metformin alone. Bofanglutide is given as a shot under the skin every two weeks, and researchers compare it to semaglutide, a weekly injection…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Phase: PHASE3 • Sponsor: Carnot Laboratories • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New diabetes shot UBT38006 enters first human safety trial
Disease control Not yet recruitingThis early-stage trial tests a single injection of UBT38006 in 43 healthy adult men to see if it is safe and how the body processes it. Participants receive either the drug, a placebo, or an active comparator (insulin degludec). The goal is to gather safety data and measure drug …
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Phase: PHASE1 • Sponsor: The United Bio-Technology (Hengqin) Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New scoring tool aims to reverse type 2 diabetes with personalized plans
Disease control Not yet recruitingThis study tests a new tool called the Snouda Metabolic Score (SMS) that helps doctors identify the specific metabolic problems driving Type 2 Diabetes in each patient. 150 adults will follow a personalized 24-week lifestyle and nutrition plan based on their SMS results. The goal…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Phase: NA • Sponsor: Salah Snouda • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Smart sensors vs. finger pricks: which works better for diabetes?
Disease control Not yet recruitingThis study compares two glucose monitoring methods—continuous glucose monitors (CGM) and traditional finger-prick tests—in adults with type 2 diabetes who are taking the drug dapagliflozin. The 120 participants will be split into two groups and followed for 12 weeks to see which …
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Phase: NA • Sponsor: The Third Xiangya Hospital of Central South University • Aim: Disease control
Last updated Jun 27, 2026 12:35 UTC
-
Can a smartphone app help young adults tame type 2 diabetes?
Disease control Not yet recruitingThis study tests a 12-week digital program led by a nurse to help young adults (ages 18-45) with type 2 diabetes better manage their condition. Participants use a web or mobile app for education, goal-setting, and direct messaging with a nurse. The goal is to see if this approach…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Phase: NA • Sponsor: Recep Turan • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Can bitter melon and snakehead fish help tame diabetes?
Disease control Not yet recruitingThis study tests whether taking a daily supplement made from bitter melon extract and snakehead fish powder can help lower blood sugar in adults with type 2 diabetes. About 80 participants will take either the supplement or a placebo for 4 weeks. The goal is to see if this natura…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Phase: NA • Sponsor: Universitas Muhammadiyah Surakarta • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Can a common diabetes drug protect the heart? new trial aims to find out
Disease control Not yet recruitingThis Phase 3 trial will test whether glimepiride, a standard diabetes pill, can reduce the risk of heart-related death, heart transplant, or worsening heart failure in people with type 2 diabetes and chronic heart failure. About 1,484 participants will receive either glimepiride …
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Phase: PHASE3 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:04 UTC
-
Diabetes remission possible without drugs? new trial investigates lifestyle overhaul
Disease control Not yet recruitingThis study tests whether a personalized diet, exercise, sleep, and counseling program can help adults with type 2 diabetes achieve remission. 120 participants will follow the program for 6 months, then be monitored for another 12. The goal is to see if blood sugar levels can retu…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Phase: NA • Sponsor: Parc Sanitari Pere Virgili • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Texting your way to better health: WhatsApp trial for stroke and diabetes
Disease control Not yet recruitingThis study tests whether adding WhatsApp-based education and counseling to standard care helps stroke patients with type 2 diabetes improve their lifestyle, blood sugar control, and disease knowledge. 84 participants will be split into two groups: one gets routine education, the …
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Phase: NA • Sponsor: Gaziler Physical Medicine and Rehabilitation Education and Research Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Tailored nursing care aims to tame blood sugar swings in type 2 diabetes
Disease control Not yet recruitingThis study tests whether individualized nursing interventions and education can help people with type 2 diabetes better manage their blood sugar levels. Researchers will provide personalized care and follow-up to 72 participants, measuring blood glucose, HbA1c, and self-managemen…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Phase: NA • Sponsor: Ataturk University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New 6-Month TB drug combo tested in diabetic patients
Disease control Not yet recruitingThis study tests a 6-month treatment regimen containing pretomanid for people with drug-resistant tuberculosis who also have type 2 diabetes. Researchers will compare how well the treatment works and how safe it is in diabetic patients versus non-diabetic patients. The goal is to…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Sponsor: Wuhan Pulmonary Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New diabetes shot aims to beat semaglutide in early trial
Disease control Not yet recruitingThis Phase 2 study tests an experimental drug called PG-102, given as a weekly injection, in 80 adults with type 2 diabetes. Participants will receive either PG-102, a placebo, or the approved drug semaglutide for 24 weeks. The main goal is to see how well PG-102 lowers blood sug…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Phase: PHASE2 • Sponsor: ProGen. Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
AI health coach aims to tame diabetes in indonesia
Disease control Not yet recruitingThis study tests whether a 12-week virtual health coaching program powered by artificial intelligence can improve blood sugar control in adults with type 2 diabetes. 206 participants in Indonesia will be randomly assigned to use the DIACOACH app or receive standard diabetes educa…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Phase: NA • Sponsor: Hasanuddin University • Aim: Disease control
Last updated Jun 26, 2026 16:24 UTC
-
Can a smart carb diet tame type 2 diabetes?
Disease control Not yet recruitingThis study will test whether a diet with carefully chosen carbohydrates can improve blood sugar control in people with type 2 diabetes. 150 adults will try both an optimized carbohydrate diet and a standard diabetes diet for 12 weeks each, with a break in between. The goal is to …
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Phase: NA • Sponsor: Shanghai 6th People's Hospital • Aim: Disease control
Last updated Jun 26, 2026 16:16 UTC
-
New CGM training program aims to help seniors with diabetes
Symptom relief Not yet recruitingThis study tests a three-session training program to help older adults (65+) who use insulin learn to use a continuous glucose monitor (CGM). Participants will be randomly assigned to the program or standard training. The goal is to see if the program improves how often they wear…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Phase: NA • Sponsor: University of North Carolina, Chapel Hill • Aim: Symptom relief
Last updated Jun 28, 2026 00:00 UTC
-
Mindfulness may ease diabetes stress, study hopes
Symptom relief Not yet recruitingThis study will test a mindfulness-based education program for adults with type 2 diabetes. The goal is to see if it reduces diabetes-related distress and helps people feel more empowered to manage their condition. 70 participants will take part in group sessions that combine min…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Phase: NA • Sponsor: Ataturk University • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
Talking your way to better blood sugar: new study tests storytelling as diabetes tool
Symptom relief Not yet recruitingThis study tests whether a structured storytelling education program can help adults with type 2 diabetes improve their blood sugar control. About 226 participants will either receive standard care or standard care plus two face-to-face storytelling sessions and four brief phone …
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Phase: NA • Sponsor: Mustafa Kemal University • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC
-
Scented foot massage may soothe diabetic nerve pain
Symptom relief Not yet recruitingThis study tests whether aromatherapy foot massage can reduce neuropathic pain in people with type 2 diabetes. 78 participants will massage their feet for 10 minutes, three times a week for 4 weeks. Researchers will compare the effects of an aromatherapy oil versus a plain oil to…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Phase: NA • Sponsor: TC Erciyes University • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Scientists launch study to decode why diabetes affects people differently
Knowledge-focused Not yet recruitingThe EXPAND study is a research project that will enroll 440 adults with and without pancreatic conditions to understand why type 2 diabetes varies so much from person to person. Researchers will collect data on metabolism, genetics, and pancreas health to identify distinct diabet…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Knowledge-focused
Last updated Jun 28, 2026 00:00 UTC
-
New Non-Invasive devices aim to spot hidden blood vessel damage
Knowledge-focused Not yet recruitingThis study will test two new non-invasive devices (HEMI and SPG-NINOX) that measure small blood vessel function in 165 adults. Participants include healthy volunteers and people with high blood pressure, type 2 diabetes, or chronic kidney disease. The goal is to see if these devi…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Phase: NA • Sponsor: Institut National de la Santé Et de la Recherche Médicale, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
5-Year study to uncover hidden triggers of diabetes and hypertension
Knowledge-focused Not yet recruitingThis study follows 2,500 adults in Mexico aged 18 to 65 who do not yet have type 2 diabetes or high blood pressure. Over five years, researchers will track their health through yearly check-ups, blood tests, and lifestyle questionnaires. The goal is to identify what factors incre…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Sponsor: Coordinación de Investigación en Salud, Mexico • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:32 UTC
-
New study eyes Tirzepatide's hidden impact on joints and heart
Knowledge-focused Not yet recruitingThis observational study in Mexico will follow 30 adults already taking tirzepatide for conditions like diabetes or obesity. Researchers will use MRI scans of the knees, CT scans of the heart, and body composition tests to see how the drug affects cartilage, heart fat, and overal…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Sponsor: JULIO GRANADOS MONTIEL • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:31 UTC
-
Could poop transplants treat diabetes and heart disease?
Knowledge-focused Not yet recruitingThis pilot study tests whether fecal microbiota transplantation (FMT) can change the gut microbiome in 30 people with type 2 diabetes and stable coronary artery disease. Participants receive processed stool from healthy donors via colonoscopy. The goal is to see if this alters gu…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Phase: NA • Sponsor: University of Zurich • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:05 UTC
-
Sugar substitutes under scrutiny: could they harm blood sugar control?
Knowledge-focused Not yet recruitingThis study looks at how two common artificial sweeteners, sucralose and saccharin, affect blood sugar control and gut bacteria in adults with type 2 diabetes. Over 33 participants will take each sweetener or a placebo for one week, with breaks in between. The goal is to see if th…
Matched conditions: TYPE 2 DIABETES MELLITUS (T2DM)
Phase: NA • Sponsor: National University of Malaysia • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:03 UTC